Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nassim Saighi"'
Autor:
Michela Del Prete, Frédéric Arsenault, Nassim Saighi, Wei Zhao, François-Alexandre Buteau, Anna Celler, Jean-Mathieu Beauregard
Publikováno v:
EJNMMI Physics, Vol 5, Iss 1, Pp 1-20 (2018)
Abstract Background Routine dosimetry is essential for personalized 177Lu-octreotate peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors (NETs), but practical and robust dosimetry methods are needed for wide clinical adoption. The a
Externí odkaz:
https://doaj.org/article/3eccfc665e014c9e95d5bc46abb54520
Autor:
Michela Del Prete, Louis-Olivier Bouchard, Alexis Beaulieu, Nassim Saighi, François-Alexandre Buteau, Frédéric Arsenault, Jean-Mathieu Beauregard
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 46:728-742
Peptide receptor radionuclide therapy (PRRT) is mostly administered using a fixed injected activity (IA) per cycle. This empiric regime results in highly variable absorbed doses to the critical organs and undertreatment of the majority of patients. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f314bcc2b7042513ace645f573b5ea02
https://doi.org/10.1007/s00259-018-4209-7
https://doi.org/10.1007/s00259-018-4209-7
Autor:
François-Alexandre Buteau, Nassim Saighi, Michela Del Prete, Anna Celler, Frédéric Arsenault, Wei Zhao, Jean-Mathieu Beauregard
Publikováno v:
EJNMMI Physics
EJNMMI Physics, Vol 5, Iss 1, Pp 1-20 (2018)
EJNMMI Physics, Vol 5, Iss 1, Pp 1-20 (2018)
Background Routine dosimetry is essential for personalized 177Lu-octreotate peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors (NETs), but practical and robust dosimetry methods are needed for wide clinical adoption. The aim of thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b2e51821460b312716f821f1749ac53
https://doi.org/10.1186/s40658-018-0224-9
https://doi.org/10.1186/s40658-018-0224-9
Autor:
Michela, Del Prete, François-Alexandre, Buteau, Frédéric, Arsenault, Nassim, Saighi, Louis-Olivier, Bouchard, Alexis, Beaulieu, Jean-Mathieu, Beauregard
Publikováno v:
European journal of nuclear medicine and molecular imaging. 46(3)
Peptide receptor radionuclide therapy (PRRT) is mostly administered using a fixed injected activity (IA) per cycle. This empiric regime results in highly variable absorbed doses to the critical organs and undertreatment of the majority of patients. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9178b438b1612896c878e3c660689d09
https://pubmed.ncbi.nlm.nih.gov/30506283
https://pubmed.ncbi.nlm.nih.gov/30506283